Radiopharm Theranostics Limited ( RADX) - Key Metrics
RADX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $35.59 | -$725.60 | -$814.49 | $0 |
| 2025Q2 | $34.54 | -$672.18 | -$565.17 | -$565.17 |
| 2024Q2 | $0 | $0 | $0 | $0 |
| 2024Q1 | $0 | $0 | $0 | $0 |
| 2023Q4 | $0 | $0 | $0 | $0 |
RADX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | 0.00 |
| 2025Q2 | 0% | 0.00 |
| 2024Q2 | 0% | 0 |
| 2024Q1 | 0% | 0 |
| 2023Q4 | 0% | 0 |
RADX
Price: $1.01
52 week price:
Earnings Per Share: -3.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.8 million